Avego BioScience Capital is Avego’s venture capital strategy, backing biotech and life sciences companies at pivotal drug-development stages to advance therapies through clinical trials. The firm invests from early-stage venture through later-stage rounds across the United States and Europe, with offices in Alpharetta, Georgia and New York. Its sector focus includes biotechnology, pharmaceuticals, oncology, HealthTech and medical devices.